Clinical Trial Details
| Trial ID: | L3307 |
| Source ID: | NCT06362265 |
| Associated Drug: | Ly3209590 |
| Title: | A Study to Evaluate Pharmacokinetics of LY3209590 in Pediatric Participants With Type 2 Diabetes Mellitus |
| Acronym: | |
| Status: | RECRUITING |
| Study Results: | NO |
| Results: | |
| Conditions: | Type 2 Diabetes Mellitus |
| Interventions: | DRUG: LY3209590 |
| Outcome Measures: | Primary: Pharmacokinetics (PK): Area Under the Plasma Concentration Versus Time Curve (AUC) of LY3209590, Predose up to 65 days post dose|PK: Maximum Observed Plasma Concentration (Cmax) of LY3209590, Predose up to 65 days post dose | Secondary: Change from Baseline in Fasting Glucose, Baseline, 65 days |
| Sponsor/Collaborators: | Sponsor: Eli Lilly and Company |
| Gender: | ALL |
| Age: | CHILD |
| Phases: | PHASE1 |
| Enrollment: | 22 |
| Study Type: | INTERVENTIONAL |
| Study Designs: | Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: BASIC_SCIENCE |
| Start Date: | 2024-10-10 |
| Completion Date: | 2026-11 |
| Results First Posted: | |
| Last Update Posted: | 2025-03-28 |
| Locations: | Honor Health Research Institute, Scottsdale, Arizona, 85258, United States|Children's Hospital Los Angeles, Los Angeles, California, 90027, United States|Children's Healthcare of Atlanta - Center for Advanced Pediatrics, Atlanta, Georgia, 30329, United States|Centricity Research Columbus Endocrinology, Columbus, Georgia, 31904, United States|Johns Hopkins Hospital, Baltimore, Maryland, 21287, United States|Joslin Diabetes Center, Boston, Massachusetts, 02215, United States|UBMD Pediatrics, Buffalo, New York, 14203, United States|NYU Langone, New York, New York, 10016, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, 45229-3039, United States|Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, 19104, United States|Lifedoc Research - Lenox Park Drive, Memphis, Tennessee, 38115, United States |
| URL: | https://clinicaltrials.gov/show/NCT06362265 |
| Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress |
|---|